News from aeterna zentaris inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 27, 2015, 16:15 ET

Aeterna Zentaris: Data Safety Monitoring Board Recommends Continuation of Phase 3 Study of Zoptarelin Doxorubicin in Advanced Endometrial Cancer

DSMB's recommendation follows 1rst interim analysis QUÉBEC CITY, April 27, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)...

Apr 23, 2015, 07:30 ET

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc.

NEW YORK, NY, April 23, 2015 /PRNewswire/ - Crystal Research Associates, LLC announced today that it has issued an Executive Informational...

Apr 16, 2015, 07:30 ET

Aeterna Zentaris Files Additional Patent Application to Strengthen IP Protection of Zoptarelin Doxorubicin

QUÉBEC CITY, April 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that it has...

Apr 13, 2015, 07:30 ET

Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD Following Successful Meeting with FDA

All amounts are in US dollars QUÉBEC CITY, April 13, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company")...

Mar 31, 2015, 07:30 ET

Aeterna Zentaris Signs Transfer Agreement of its Discovery Library with the Medical University of South Carolina

QUÉBEC CITY, March 31, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that it has agreed...

Mar 17, 2015, 16:15 ET

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2014 Financial and Operating Results

All amounts are in US dollars QUEBEC CITY, March 17, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a...

Mar 11, 2015, 10:15 ET

Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants

QUÉBEC CITY, March 11, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the...

Mar 10, 2015, 07:30 ET

Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2014 Financial and Operating Results on March 17, 2015

QUEBEC CITY, March 10, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its fourth...

Mar 06, 2015, 08:30 ET

Aeterna Zentaris Announces Pricing of US$37 Million Public Offering of Common Shares and Warrants

QUÉBEC CITY, March 6, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the...

Mar 05, 2015, 16:08 ET

Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants

QUÉBEC CITY, March 5, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that...

Jan 06, 2015, 07:30 ET

Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco

QUÉBEC CITY, Jan. 6, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...

Dec 29, 2014, 07:30 ET

Aeterna Zentaris: Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin in Prostate Cancer Published in Clinical Cancer Research

QUÉBEC CITY, Dec. 29, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that an article...

Dec 19, 2014, 09:00 ET

Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price

QUEBEC CITY, Dec. 19, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company") announced today that it has...

Dec 01, 2014, 07:30 ET

Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin Doxorubicin in China

All amounts are in U.S. dollars QUÉBEC CITY, Dec. 1, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") and...

Nov 20, 2014, 07:30 ET

Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer

Patient recruitment in line to secure expected interim analysis in H1 2015 All amounts are in U.S. dollars (unless otherwise noted) QUÉBEC...

Nov 06, 2014, 07:00 ET

FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency

QUÉBEC CITY, Nov. 6, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that the Company...

Nov 04, 2014, 16:30 ET

Aeterna Zentaris Reports Third Quarter 2014 Financial and Operating Results

All amounts are in US dollars QUEBEC CITY, Nov. 4, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a...

Oct 28, 2014, 07:30 ET

Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014

QUEBEC CITY, Oct. 28, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its third quarter...

Oct 27, 2014, 07:30 ET

Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel®

QUÉBEC CITY, Oct. 27, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the formal...

Oct 07, 2014, 07:30 ET

Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and Corporate Secretary

QUÉBEC CITY, Oct. 7, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced the...